Development, manufacturing, and distribution of injectable medicines for healthcare facilities worldwide.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: March 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
Delpharm
A
Development and manufacturing of pharmaceuticals for third parties, including sterile and non-sterile liquids, solids, semi-solids, and biotech forms.
Laboratoire Aguettant
A
Specialized in essential hospital injectable drugs and ready-to-use medicines, focusing on patient safety and therapeutic solutions for hospitals.
Octapharma France
B
Development and distribution of therapeutic pharmaceutical products for healthcare professionals and patients.
Initiatives identified among leaders
Certification PSCI pour 100% des sites d’ici 2027 pour améliorer sécurité des procédés.
“Delpharm s’est engagé à ce que 100% de ses sites s...” - DelpharmFormations sécurité obligatoires et régulières pour réduire les accidents du travail
“Tous les salariés des sites français reçoivent une...” - Laboratoire AguettantPublication d’un rapport RSE et diagnostic ISO 26000 pour Lingolsheim.
“Octapharma France a publié un rapport sur sa démar...” - Octapharma France56% of similar organizations communicate on CSR issues
+1854 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports